Roche wants to treat Alzheimer’s before memory loss begins. Can a blood test and Brainshuttle antibody make prevention possible?
Roche starts Phase 3 PrevenTRON to test trontinemab before Alzheimer’s symptoms, linking amyloid therapy with pTau217 biomarker screening.